Search clinical trials for: Herceptin®
Total 14242 results
-
Samsung Bioepis Co., Ltd.Completed
-
Shanghai Henlius BiotechCompleted
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
MedSIRTerminatedAdvanced Breast CancerSpain
-
University of Michigan Rogel Cancer CenterTerminatedBreast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; ExelixisCompletedBreast Cancer | Brain Tumor - MetastaticUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerItaly, Spain, Sweden, China, Hong Kong, Canada, South Africa, Ukraine, United States, United Kingdom, Russian Federation, Taiwan, Australia, Mexico, Turkey, Israel, Poland, Bulgaria, Germany, France, Netherlands, Norway, India, Hungary, Brazi... and more
-
PfizerCompletedCarcinoma, Metastatic BreastUnited States
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
University Hospital, Clermont-FerrandCompletedObstructive Sleep Apnea Syndrome | ObesityFrance
-
PfizerCompleted
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Hoffmann-La RocheCompleted
-
Armando Santoro, MDTerminated
-
Prestige Biopharma LimitedCompleted
-
University of CincinnatiOhio Third Frontier; Wright Center of Innovation in Biomedical ImagingActive, not recruitingHealthcare Facility Environment - ImagingUnited States
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
Swiss Group for Clinical Cancer ResearchTerminatedBreast CancerSwitzerland, Italy
-
Alteogen, Inc.Cristália Produtos Químicos Farmacêuticos Ltda.Completed
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
EirGenix, Inc.Completed
-
MacroGenicsZai Lab (Shanghai) Co., Ltd.Active, not recruitingGastric Cancer | Gastroesophageal Junction Cancer | HER2-positive Gastric CancerKorea, Republic of, United States, China, Italy, Taiwan, Germany, Singapore, United Kingdom, Poland
-
Mylan Pharmaceuticals IncMylan GmbHCompleted
-
CelgeneCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Qilu Pharmaceutical Co., Ltd.Completed
-
Shanghai Henlius BiotechCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Completed
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
Augusta UniversityUniversity of Iowa; Teikyo UniversityRecruitingFructose IntoleranceUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHER2-positive Metastatic Breast CancerChina
-
University of North Carolina, Chapel HillCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaUnited States, Australia, Brazil, Chile, China, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Susanne CrocamoCompletedNeoplasms | Neoplasms by Site | Breast Cancer | Breast DiseaseBrazil
-
University of FloridaCompleted
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Hoffmann-La RocheCompletedBreast NeoplasmsHungary, Italy, United Kingdom, Canada, Czechia, Bulgaria, Croatia, Dominican Republic, France, Germany, Greece, Guatemala, Hong Kong, Indonesia, Ireland, Korea, Republic of, Netherlands, Panama, Peru, Poland, Portugal, Slovakia, Spain and more
-
Hoffmann-La RocheCompleted
-
Institut CurieCentre Leon Berard; Institut Bergonié; Hoffmann-La Roche; University Hospital,... and other collaboratorsCompletedMetastatic Breast Cancer | Carcinomatous MeningitisFrance
-
Hoffmann-La RocheCompletedGastric Cancer, Gastroesophageal Junction CancerFrance
-
Maastricht University Medical CenterCompleted
-
ARCAGY/ GINECO GROUPHoffmann-La RocheTerminated
-
UNICANCERSeagen Inc.; ARCAGY/ GINECO GROUPRecruitingMetastatic Breast Cancer With a Isolated Brain ProgressionFrance
-
Qilu Pharmaceutical Co., Ltd.Completed
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheEuropean Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical... and other collaboratorsCompletedBreast CancerFrance, Spain, Switzerland, Greece, Italy, Korea, Republic of, Australia, Canada, Poland, Belgium, United Kingdom, Netherlands, Germany, Chile, Ireland, Portugal, South Africa, Sweden, China, Austria, Hungary, Brazil, Colombia, Thailand, Denma... and more
-
Hoffmann-La RocheCompletedNeoplasmsSpain, Germany, Russian Federation, United Kingdom, Korea, Republic of, New Zealand, Hungary, Serbia, China, Australia, Belgium, France, Portugal, Israel, Guatemala, Poland, Panama